Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

View source ↗

Summary

Completed clinical trial evaluating the level of CD59 on red and white blood cells in patients with paroxysmal nocturnal hemoglobinuria and bone marrow failure …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hemoglobinuria | Status: COMPLETED